Society for Immunotherapy of Cancer

Society for Immunotherapy of Cancer SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven organization specifically dedicated to professionals working in the field of cancer immunology and immunotherapy. Established in 1984, SITC is a 501(c)(3) not-for-profit organization with a growing constituency of academic, government, industry, clinical and basic scientists, and practitioners from around the world

. Through emphasis on high-caliber scientific meetings; dedication to education and outreach activities; focus on initiatives of major importance in the field; and commitment to collaborations with like-minded domestic and international organizations, government and regulatory agencies, associations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community.

Learn how immune-based approaches are shaping the future of early cancer detection in Webinar 3 of the 2026 SITC Computa...
06/19/2026

Learn how immune-based approaches are shaping the future of early cancer detection in Webinar 3 of the 2026 SITC Computational IO Series on July 9. Don’t miss insights from leaders in computational IO: https://www.sitcancer.org/edu/webinars/computational

How are the next generation of IO biotech companies being built? Join this opening panel at the NYSE program to hear CEO...
06/18/2026

How are the next generation of IO biotech companies being built? Join this opening panel at the NYSE program to hear CEOs and industry leaders discuss funding, innovation, partnerships and growth strategies shaping the future of immuno-oncology. Registration ends Sunday, Register now! Sitcancer.org/2026-sitc-biotech-nyse

Join leading experts as they explore emerging modalities Beyond PD-1, discussing vaccines, multi-/bi-specific antibodies...
06/18/2026

Join leading experts as they explore emerging modalities Beyond PD-1, discussing vaccines, multi-/bi-specific antibodies, and the future of IO drug development. Gain insights from industry leaders and innovators shaping the next generation of cancer immunotherapies. https://www.sitcancer.org/edu/edu-sitc-biotech-initiative/eu-io-summit

Use our Connect-a-Colleague Tool to refer your colleagues to join ! The top referrer will be recognized at . sitcancer...
06/18/2026

Use our Connect-a-Colleague Tool to refer your colleagues to join ! The top referrer will be recognized at . sitcancer.org/connect-a-colleague

One week left to submit your regular and Early Career Investigator Award Abstracts to ! Do not miss this opportunity to...
06/18/2026

One week left to submit your regular and Early Career Investigator Award Abstracts to ! Do not miss this opportunity to share your exciting new research at our 41st Annual Meeting. All accepted abstracts are published in the Journal for ImmunoTherapy of Cancer (JITC). Learn more: sitcancer.org/2026/abstracts/abstract-submission/abstracts-yia

Are you devoted to ? Renew your SITC membership today to continue collaborating with a global network of professionals ...
06/17/2026

Are you devoted to ? Renew your SITC membership today to continue collaborating with a global network of professionals dedicated to helping improve cancer patient outcomes. https://www.sitcancer.org/renew

Register for our 41st Annual Meeting and Pre-Conference Programs. provides a multidisciplinary educational & interacti...
06/17/2026

Register for our 41st Annual Meeting and Pre-Conference Programs. provides a multidisciplinary educational & interactive environment focused on improving outcomes for cancer patients. Attend in person or virtually: https://www.sitcancer.org/2026/home

Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical developme...
06/16/2026

Don’t miss the first webinar in our Deep Dive Series, happening June 30th! Explore the mechanisms and clinical development of PD-1/VEGF bispecifics with expert faculty examining emerging biology, engineering strategies, and the latest clinical data. Register now: https://www.sitcancer.org/edu/webinars/targets-for-cancer-io

Join JACI 2026 to discuss various trends in cancer immunity such as immunotherapy resistance and personalized cancer IO!...
06/15/2026

Join JACI 2026 to discuss various trends in cancer immunity such as immunotherapy resistance and personalized cancer IO! Organized in collaboration with the Society for Immunotherapy of Cancer the Japanese Association of Cancer Immunology is hosting their 30th Annual Meeting July 22–24, in Kagawa, Japan or virtual.

Featured presentations include:
• Dr. Shimon Sakaguchi, Osaka University – 2025 Nobel Prize Recipient in Physiology or Medicine
Special Lecture: “Cancer immunotherapy targeting regulatory T cells”

• Lili Yang, PhD, UCLA – SITC Speaker
“Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis”

Learn more and join leaders in the field: https://ow.ly/vCjj50Z2eJY

Address

555 E. Wells Street Ste. 1100
Milwaukee, WI
53202

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

(414) 271-2456

Website

Alerts

Be the first to know and let us send you an email when Society for Immunotherapy of Cancer posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Society for Immunotherapy of Cancer:

Shortcuts

Share

Category